Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin. - Kuhnast, S; van der Tuin, SJ; van der Hoorn, JW (Eur Heart J, 2015)
et al.